BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20503385)

  • 1. Shop talk: Sugars, bones, and a disease called multiple hereditary exostoses.
    Roehl HH; Pacifici M
    Dev Dyn; 2010 Jun; 239(6):1901-4. PubMed ID: 20503385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondrosarcoma in a family with multiple hereditary exostoses.
    Kivioja A; Ervasti H; Kinnunen J; Kaitila I; Wolf M; Böhling T
    J Bone Joint Surg Br; 2000 Mar; 82(2):261-6. PubMed ID: 10755438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
    Jones KB; Pacifici M; Hilton MJ
    Connect Tissue Res; 2014 Apr; 55(2):80-8. PubMed ID: 24409815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
    Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
    J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.
    Huegel J; Sgariglia F; Enomoto-Iwamoto M; Koyama E; Dormans JP; Pacifici M
    Dev Dyn; 2013 Sep; 242(9):1021-32. PubMed ID: 23821404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel nonsense mutation of the EXT1 gene in an Argentinian patient with multiple hereditary exostoses: a case report.
    Delgado MA; Sarrión P; Azar N; Zecchini L; Robledo HH; Segura F; Balcells S; Grinberg D; Dodelson de Kremer R; Asteggiano CG
    J Bone Joint Surg Am; 2012 Jun; 94(11):e76. PubMed ID: 22637216
    [No Abstract]   [Full Text] [Related]  

  • 8. The neoplastic pathogenesis of solitary and multiple osteochondromas.
    Porter DE; Simpson AH
    J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.
    Sinha S; Mundy C; Bechtold T; Sgariglia F; Ibrahim MM; Billings PC; Carroll K; Koyama E; Jones KB; Pacifici M
    PLoS Genet; 2017 Apr; 13(4):e1006742. PubMed ID: 28445472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.
    Inubushi T; Lemire I; Irie F; Yamaguchi Y
    J Bone Miner Res; 2018 Apr; 33(4):658-666. PubMed ID: 29120519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone scintigraphy in hereditary multiple exostoses.
    Epstein DA; Levin EJ
    AJR Am J Roentgenol; 1978 Feb; 130(2):331-3. PubMed ID: 414588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal scarring with keloid formation after osteochondroma excision in children with multiple hereditary exostoses.
    Hosalkar H; Greenberg J; Gaugler RL; Garg S; Dormans JP
    J Pediatr Orthop; 2007; 27(3):333-7. PubMed ID: 17414021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple osteochondromas.
    Bovée JV
    Orphanet J Rare Dis; 2008 Feb; 3():3. PubMed ID: 18271966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.
    Mundy C; Yang E; Takano H; Billings PC; Pacifici M
    J Biol Chem; 2018 May; 293(20):7703-7716. PubMed ID: 29622677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling systems affecting the severity of multiple osteochondromas.
    Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
    Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical problems in multiple osteochondroma].
    Ham SJ; de Lange J; van der Zwan AL; Schaap GR; van der Woude HJ; Heeg M
    Ned Tijdschr Geneeskd; 2012; 156(11):A4254. PubMed ID: 22414670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
    Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three patients with hereditary multiple exostoses and malignant degeneration of an osteochondroma located in the pelvis].
    Ham SJ; Heeg M; van Horn JR
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1732-8. PubMed ID: 15468904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients.
    Benoist-Lasselin C; de Margerie E; Gibbs L; Cormier S; Silve C; Nicolas G; LeMerrer M; Mallet JF; Munnich A; Bonaventure J; Zylberberg L; Legeai-Mallet L
    Bone; 2006 Jul; 39(1):17-26. PubMed ID: 16476576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates.
    Cuellar A; Reddi AH
    Int Orthop; 2013 Aug; 37(8):1591-6. PubMed ID: 23771188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.